Axxion S.A.’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Axxion S.A.'s ABBV Position: Q3 2026 in Review
Axxion S.A. increased its AbbVie (ABBV) stake by 4.9% in Q3 2026, buying an estimated $123K and bringing the position to 10,189 shares worth $2.67M. The position accounts for 0.18% of the portfolio, ranked #98.
Axxion S.A. first reported a position in ABBV in Q2 2026 and has held it in 2 quarters since. 4,250 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Axxion S.A. held 10,189 shares of AbbVie worth $2.67M as of Q3 2026.
- Axxion S.A. bought 479 AbbVie shares in Q3 2026, an estimated $123K.
- AbbVie made up 0.18% of Axxion S.A.'s portfolio in Q3 2026, its #98 holding.
- Axxion S.A. first reported a position in AbbVie in Q2 2026 and has held it in 2 quarters since.
- 4,250 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Axxion S.A.'s 13F filing for Q3 2026, filed 22 Oct 2026.